Bryan A. Killinger

1.4k total citations
25 papers, 943 citations indexed

About

Bryan A. Killinger is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bryan A. Killinger has authored 25 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Molecular Biology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bryan A. Killinger's work include Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). Bryan A. Killinger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (14 papers), Alzheimer's disease research and treatments (4 papers) and RNA Interference and Gene Delivery (4 papers). Bryan A. Killinger collaborates with scholars based in United States, Switzerland and Canada. Bryan A. Killinger's co-authors include Viviane Labrie, Anna Moszczyńska, Patrik Brundin, Jeffrey H. Kordower, Lena Brundin, Honglei Chen, Peipei Li, Zachary Madaj, Nolwen L. Rey and Daniel Lindqvist and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Neuroscience.

In The Last Decade

Bryan A. Killinger

25 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan A. Killinger United States 20 413 402 210 206 123 25 943
Xin Fang China 19 472 1.1× 310 0.8× 99 0.5× 243 1.2× 162 1.3× 57 1.0k
Luca Magistrelli Italy 16 232 0.6× 489 1.2× 230 1.1× 152 0.7× 316 2.6× 34 928
Larisa Ryskalin Italy 21 379 0.9× 187 0.5× 192 0.9× 175 0.8× 107 0.9× 57 1.0k
Yinxia Chao Singapore 17 542 1.3× 608 1.5× 339 1.6× 177 0.9× 338 2.7× 33 1.4k
Sangjune Kim South Korea 15 602 1.5× 871 2.2× 379 1.8× 442 2.1× 288 2.3× 37 1.6k
Rebecca L. Wallings United States 10 421 1.0× 760 1.9× 294 1.4× 361 1.8× 389 3.2× 19 1.3k
Wenyan Kang China 19 363 0.9× 677 1.7× 247 1.2× 281 1.4× 254 2.1× 50 1.3k
Uday B. Muthane India 24 456 1.1× 1.0k 2.6× 625 3.0× 260 1.3× 225 1.8× 55 1.7k
Zhi-Lan Zhou China 10 584 1.4× 357 0.9× 74 0.4× 237 1.2× 176 1.4× 15 1.0k
Sara Batelli Italy 13 229 0.6× 165 0.4× 250 1.2× 280 1.4× 89 0.7× 25 819

Countries citing papers authored by Bryan A. Killinger

Since Specialization
Citations

This map shows the geographic impact of Bryan A. Killinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan A. Killinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan A. Killinger more than expected).

Fields of papers citing papers by Bryan A. Killinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan A. Killinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan A. Killinger. The network helps show where Bryan A. Killinger may publish in the future.

Co-authorship network of co-authors of Bryan A. Killinger

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan A. Killinger. A scholar is included among the top collaborators of Bryan A. Killinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan A. Killinger. Bryan A. Killinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Betts, Dean H., et al.. (2025). Proximity proteomics reveals unique and shared pathological features between multiple system atrophy and Parkinson’s disease. Acta Neuropathologica Communications. 13(1). 65–65. 1 indexed citations
2.
Kordower, Jeffrey H., et al.. (2024). Alpha-synuclein aggregates are phosphatase resistant. Acta Neuropathologica Communications. 12(1). 84–84. 3 indexed citations
3.
Killinger, Bryan A., et al.. (2023). Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis. npj Parkinson s Disease. 9(1). 43–43. 10 indexed citations
4.
Killinger, Bryan A., Lee Marshall, Yaping Chu, et al.. (2022). In situ proximity labeling identifies Lewy pathology molecular interactions in the human brain. Proceedings of the National Academy of Sciences. 119(5). 28 indexed citations
5.
Gordevičius, Juozas, Peipei Li, Lee Marshall, et al.. (2021). Epigenetic inactivation of the autophagy–lysosomal system in appendix in Parkinson’s disease. Nature Communications. 12(1). 5134–5134. 22 indexed citations
6.
Li, Peipei, Bryan A. Killinger, Elizabeth Ensink, et al.. (2021). Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease. Metabolites. 11(1). 29–29. 97 indexed citations
7.
Chen, Honglei, Keran Wang, Filip Scheperjans, & Bryan A. Killinger. (2021). Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses. Neurobiology of Disease. 163. 105601–105601. 20 indexed citations
8.
Marshall, Lee, Bryan A. Killinger, Elizabeth Ensink, et al.. (2020). Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective. Nature Neuroscience. 23(10). 1203–1214. 64 indexed citations
9.
Killinger, Bryan A. & Viviane Labrie. (2019). The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?. Journal of Parkinson s Disease. 9(s2). S345–S358. 24 indexed citations
10.
Pai, Shraddha, Peipei Li, Bryan A. Killinger, et al.. (2019). Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis. Nature Communications. 10(1). 2046–2046. 49 indexed citations
11.
Killinger, Bryan A., Ronald Melki, Patrik Brundin, & Jeffrey H. Kordower. (2019). Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room. npj Parkinson s Disease. 5(1). 23–23. 61 indexed citations
12.
Killinger, Bryan A. & Viviane Labrie. (2017). Vertebrate food products as a potential source of prion-like α-synuclein. npj Parkinson s Disease. 3(1). 33–33. 21 indexed citations
13.
Kesharwani, Prashant, Bryan A. Killinger, Anna Moszczyńska, et al.. (2016). Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures. Journal of Colloid and Interface Science. 484. 33–43. 54 indexed citations
14.
Killinger, Bryan A. & Anna Moszczyńska. (2016). Characterization of α-Synuclein Multimer Stoichiometry in Complex Biological Samples by Electrophoresis. Analytical Chemistry. 88(7). 4071–4084. 9 indexed citations
15.
Xie, Yuran, Bryan A. Killinger, Anna Moszczyńska, & Olivia M. Merkel. (2016). Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine. Molecules. 21(10). 1334–1334. 38 indexed citations
16.
Moszczyńska, Anna, et al.. (2015). Neurotoxic Methamphetamine Doses Increase LINE-1 Expression in the Neurogenic Zones of the Adult Rat Brain. Scientific Reports. 5(1). 14356–14356. 29 indexed citations
17.
Killinger, Bryan A., et al.. (2014). Single and Binge Methamphetamine Administrations Have Different Effects on the Levels of Dopamine D2 Autoreceptor and Dopamine Transporter in Rat Striatum. International Journal of Molecular Sciences. 15(4). 5884–5906. 22 indexed citations
18.
Liu, Bin, et al.. (2013). Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity. Experimental Neurology. 247. 359–372. 33 indexed citations
19.
Killinger, Bryan A., et al.. (2010). Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats. Pharmacology Biochemistry and Behavior. 96(3). 260–265. 24 indexed citations
20.
Baker, Lisa E., et al.. (2009). Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats. Psychopharmacology. 203(2). 203–211. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Fang Breakdown of academic impact, for papers by Luca Magistrelli Breakdown of academic impact, for papers by Larisa Ryskalin Breakdown of academic impact, for papers by Yinxia Chao Breakdown of academic impact, for papers by Sangjune Kim Breakdown of academic impact, for papers by Rebecca L. Wallings Breakdown of academic impact, for papers by Wenyan Kang Breakdown of academic impact, for papers by Uday B. Muthane Breakdown of academic impact, for papers by Zhi-Lan Zhou Breakdown of academic impact, for papers by Sara Batelli
Rankless by CCL
2026